Language Matters: Exploring the Impact of Language Concordance on Fertility Treatment Progression

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorWashington University School of Medicine

About this trial

Currently, patients presenting to the Fertility and Reproductive Medicine Center meet with an English-speaking provider and communicate through an interpreter, as none of the physicians speak Spanish. However, this study PI is a native Spanish speaker and certified bilingual clinician. Thus, this study is looking to evaluate whether or not the use of an interpreter delays completion of testing and initiation of fertility treatment. The medically indicated testing, procedures, and course of treatment will not be altered as a result of participation in the study. Participants will be asked to complete a survey in their preferred language to gauge satisfaction and communication efficacy.

This proposed study is significant as it seeks to address a critical gap in the understanding of how language concordance between healthcare providers and patients influences treatment outcomes in fertility care. With Spanish being the most commonly spoken non-English language in the U.S., evaluating the impact of Spanish language skills in medical care is both timely and essential. This research will shed light on whether Spanish-speaking patients experience better treatment progression and outcomes when cared for by language-concordant providers versus when interpreters are used in fertility care.

This prospective study will be conducted at Washington University's Fertility and Reproductive Medicine Center over a 12-month period. The investigators aim to enroll a total of 70 Spanish-speaking patients, based on previous patient trends at the Center 35 will be randomized to the intervention group (being evaluated and treated by a Spanish-speaking provider), and 35 will be randomized to standard of care (communicating with an English-speaking provider through an interpreter).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Must be greater than 18 years old

Preferred language must be Spanish speaking

Must be seeking fertility treatment

Disqualifiers

Preferred language English

Not currently seeking fertility care

Less than 18 years old

Trial design

Design model

Parallel

Treatments tested in this trial

  • Spanish-Speaking Provider

    Behavioral

    Spanish speaking patients will be seen by our Spanish-speaking provider

Treatment groups

70 Participants
are divided into 2 treatment groups
Group A: Spanish speaking patients seen by English-Speaking ProviderNo intervention 0 interventions
Group B: Spanish-Speaking patients seen by a Spanish-speaking providerExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Completion of diagnostic tests

The primary outcome is the time from the patients initial consultation to the completion of the recommended fertility diagnostic tests such as blood work or a pelvic ultrasound. Given that the tests are typically specific to the menstrual cycle, the investigators want know if the patients are completing their work-up faster when they see a Spanish-speaking physician thus understanding the instructions versus when the English speaking providers use an interpreter. The work-up only includes the labs and imaging that was recommended during their initial visit. The outcome will be measured by the unit - days.

Time frame
90 days from initial consultation.

Secondary outcomes

1

Patient satisfaction and communication

Patient satisfaction and communication effectiveness, assessed through surveys administered after the initial consultation. The survey is a validated survey that uses a point system metric to conclude patient satisfaction similar to the PHQ-9 survey.

Time frame
90 days from initial consultation.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.